The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research
Status: Recruiting
Location: See location...
Intervention Type: Procedure, Radiation, Drug
Study Type: Observational
SUMMARY
This study is a prospective, noninteractive, observational, and longitudinal study aimed at assessing the treatment pattern and clinical outcome of acromegaly in China.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
View:
• Be able and willing to sign the informed consent form (ICF)
• Male, female, age 18-75 years old (including 18 years old and 75 years old).
• Compliance with acromegaly diagnostic criteria:
‣ At least one laboratory or medical record shows that the patient is random GH ≥ 2.5 μg / L
⁃ At least one checklist or medical record shows radiographic evidence that the patient has a pituitary tumor
Locations
Other Locations
China
China Acromegaly Organization
RECRUITING
Guangzhou
Time Frame
Start Date: 2017-12-15
Estimated Completion Date: 2051-01-30
Participants
Target number of participants: 1965
Treatments
Surgical treatment
The subject was received transnasal butterfly surgery.
Drug therapy
The subject was received drug treatment including somatostatin analogues such as sandostatin and lanreotide, dopamine receptor agonists and GH receptor antagonists.
Radiotherapeutics
he subject was received radiotherapy methods including radiotherapy, linear accelerator X knife, gamma knife and so on.
Related Therapeutic Areas
Sponsors
Leads: Ginkgo Leaf Center for Rare Disorders